Loading...

Brilliant Violet 421™ Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
SAv-Brilliant Violet 421™
Ave. Rating
Submit a Review
Product Citations
publications
SAV_BV421_071911
Human peripheral blood lymphocytes were stained with biotinylated CD3 (filled histogram) or mouse IgG1 isotype control (open histogram), followed with SAV-Brilliant Violet 421™.
  • SAV_BV421_071911
    Human peripheral blood lymphocytes were stained with biotinylated CD3 (filled histogram) or mouse IgG1 isotype control (open histogram), followed with SAV-Brilliant Violet 421™.
See Brilliant Violet 421™ spectral data
Cat # Size Price Save
405226 100 µL ¥42,460
405225 100 µg ¥101,640
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Brilliant Violet 421™ is useful for detecting biotinylated antibodies. The excitation of Brilliant Violet 421™ by 405 nm laser light induces a fluorescence maximum emission of 421 nm.

Product Details
Technical data sheet

Product Details

Reactivity
Human,Mouse,Rat,All Species
Formulation
Cat. No. 405225: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Cat. No. 405226: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
Streptavidin was conjugated with Brilliant Violet 421™ under optimal conditions.
Concentration
405225 is bottled at 0.5 mg/ml.
405226 is bottled at 0.1 mg/ml.
(concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC, ICFC - Quality tested
ICC, IHC-F, IHC-P
Recommended Usage

Each lot of this Streptavidin-Brilliant Violet 421™ is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the Brilliant Violet 421™ conjugation. For immunofluorescent staining, we recommend using Cat. No. 405226 at dilutions ≤ 0.015 µg in 100 µL staining volume per million cells. For applications requiring high concentration of streptavidin reagent such as tetramer labeling, we recommend using Cat. No. 405225. It is recommended that the reagent be titrated for optimal performance for each application.

* Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Streptavidin-Brilliant Violet 421™ is useful as a second step reagent for indirect immunofluorescent staining when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-Brilliant Violet 421™ is 340 kD and Streptavidin alone is 52 kD.

Additional Product Notes

View more applications data using this product in immunofluorescence microscopy and labeling tetramers in flow cytometry in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Kim G, et al. 2013. J. Immunol. 190:1510. PubMed.
  2. Giltiay NV, Et al. 2013. J. Immunol. 191:2155. PubMed
  3. Sugiyama D, et al. 2013. PNAS. 110:17945. PubMed
  4. Scally SW, et al. 2013. J. Exp Med. 210:2569. PubMed
  5. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  6. Higdon LE, et al. 2014. PNAS. 111:5652. PubMed
  7. Friedman RS, et al. 2014. PNAS. 111:9223. PubMed
  8. van de Weijer ML, et al. 2014. Nat Commun. 5:3832. PubMed
  9. Mise-Omata S, et al. 2014. Int Immunol. PubMed
  10. Choo JA, et al. 2014. J Virol. 88:10613. PubMed
  11. Xing YL, et al. 2014. J Neurosci. 34:14128. PubMed
  12. Luetke-Eversloh M, et al. 2014. PLoS Pathog. 10:1004441. PubMed
  13. Poh Cm, et al. 2014. Infect Immun. 82:4854. PubMed
  14. Cabrera-Perez J, et al. 2015. J Immunol. 194:1609. PubMed
  15. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  16. Krishnaswamy JK, et al. 2015. PNAS. 112:3056. PubMed
  17. Rampuria P, et al. 2015. Int Immunol. 27:253. PubMed
Product Citations
  1. Mitra T, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.035. PubMed
  2. An X, et al. 2017. PLoS One.. 10.1371/journal.pone.0181904. PubMed
  3. Angkasekwinai P, et al. 2017. PLoS One. 10.1371/journal.pone.0184684. PubMed
  4. Petursdottir D, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01699. PubMed
  5. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  6. Wilmore JR et al. 2018. Cell host & microbe. 23(3):302-311 . PubMed
  7. Taguchi A, et al. 2017. Cell Stem Cell. 21:730. PubMed
  8. Miura M, et al. 2019. Wellcome Open Res. 3:105. PubMed
  9. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  10. Krishack PA, et al. 2019. JCI Insight. 4:6. PubMed
  11. Cirelli KM et al. 2019. Cell. 177(5):1153-1171 . PubMed
  12. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  13. Kato T, et al. 2019. Front Immunol. 10:2021. PubMed
  14. van Eeden C, et al. 2018. Cell Rep. 25:3123. PubMed
  15. Neumann B, et al. 2019. Cell Stem Cell. 25:473. PubMed
  16. Parra–Sánchez H, et al. 2019. Viruses. 1.153472222. PubMed
  17. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  18. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  19. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  20. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  21. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  22. Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
  23. Mahmoudi S, et al. 2019. Nature. 574:553. PubMed
  24. Kim JM, et al. 2020. Nat Commun. 11:2289. PubMed
  25. Wen J, et al. 2020. Cell Rep. 31:107566. PubMed
  26. Parra-Sánchez H, et al. 2018. Mol Immunol. 96:1. PubMed
  27. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  28. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  29. Clement RL, et al. 2019. Nat Immunol. 20:1360. PubMed
  30. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  31. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  32. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  33. Blomberg R, et al. 2019. Matrix Biol. 83:60. PubMed
  34. Kim G, et al. 2013. J Immunol. 190:1510. PubMed
  35. Giltiay N, et al. 2013. J Immunol. 191:2155. PubMed
  36. Sugiyama D, et al. 2013. Proc Natl Acad Sci U S A. 110:17945. PubMed
  37. Scally S, et al. 2013. J Exp Med. 210:2569. PubMed
  38. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  39. Higdon L, et al. 2014. Proc Natl Acad Sci U S A. 111:5652. PubMed
  40. Claudepierre M, et al. 2014. J Virol. 88:5242. PubMed
  41. Friedman R, et al. 2014. Proc Natl Acad Sci U S A. 111:9223. PubMed
  42. Weijer M, et al. 2014. Nat Commun. 5:3832. PubMed
  43. Mise-Omata S, et al. 2014. Int Immunol. 26:607. PubMed
  44. Choo J, et al. 2014. J Virol. 88:10613. PubMed
  45. Xing Y, et al. 2014. J Neurosci. 34:14128. PubMed
  46. Luetke-Eversloh M, et al. 2014. PLoS Pathog. 10:1004441. PubMed
  47. Poh C, et al. 2014. Infect Immun . 82:4854. PubMed
  48. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  49. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  50. Krishnaswamy J, et al. 2015. Proc Natl Acad Sci U S A. 112:3056. PubMed
  51. Lang P 2015. Int Immunol. 27:253. PubMed
  52. Liu B, et al. 2015. J Immunol. 194:3583. PubMed
  53. Sanjo H, et al. 2015. PLoS One. 10: 0128761. PubMed
  54. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  55. Cameron G, et al. 2015. J Immunol. 195: 4604 - 4614. PubMed
  56. Trivedi S, et al. 2015. Vaccine. 33: 7315-7327. PubMed
  57. Salzberger W, et al. 2015. PLoS One. 10: 0145324. PubMed
  58. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  59. Elayeb R, et al. 2016. Haematologica. 101: 209 - 218. PubMed
  60. Younis R, et al. 2016. J Immunol. 196: 1419 - 1429. PubMed
  61. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  62. Sei J, et al. 2016. PLoS One. 11: 0152192. PubMed
  63. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  64. Li H, et al. 2016. J Immunol. 196: 4064 - 4074. PubMed
  65. Bähr A, et al. 2016. PLoS One. 11: 0155676. PubMed
  66. Takizawa F, et al. 2016. J Immunol. 196: 4522 - 4535. PubMed
  67. Yang E, et al. 2016. J Immunol. 197: 934 - 941. PubMed
  68. Im S, et al. 2016. Nature. 537:417-421. PubMed
  69. Koay H, et al. 2016. Nat Immunol. 10.1038/ni.3565. PubMed
  70. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  71. Sage P, et al. 2016. Nat Immunol. 17:1436-1446. PubMed
  72. Zhu L, et al. 2016. J Cell Sci. 129: 4238 - 4251. PubMed
  73. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  74. Rowan A, et al. 2016. PLoS Pathog. 12:e1006030. PubMed
  75. Roberts E, et al. 2016. PLoS One. 11:e0168488. PubMed
  76. Lundell A, et al. 2017. Sci Rep. 7:39904. PubMed
  77. Hayashi M, et al. 2017. EBioMedicine. 15:127-136. PubMed
  78. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  79. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  80. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  81. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  82. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  83. Fra-Bido S, et al. 2021. STAR Protocols. 2(3):100499. PubMed
  84. Dan JM, et al. 2021. Science. :371. PubMed
  85. Steines L, et al. 2021. Front Immunol. 12:657894. PubMed
  86. Fries CN, et al. 2021. Sci Rep. 11:14494. PubMed
  87. Wells DK, et al. 2020. Cell. 183:818. PubMed
  88. García-Alegria E, et al. 2021. STAR Protoc. 2:100367. PubMed
  89. Zhang R, et al. 2021. MAbs. 13:1904546. PubMed
  90. Müller TR, et al. 2021. Cell Rep Med. 2:100374. PubMed
  91. Gaudette BT, et al. 2021. J Clin Invest. 131:. PubMed
  92. Xiong W, et al. 2021. Int J Mol Sci. 22:. PubMed
  93. Poon MML, et al. 2021. Sci Immunol. 6:eabl9105. PubMed
  94. Chaugule S, et al. 2021. Int J Mol Sci. 22:. PubMed
  95. Nakagawa T, et al. 2021. Cell Rep. 37:109875. PubMed
  96. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  97. Reyes RA, et al. 2021. PLoS One. 16:e0261656. PubMed
  98. Tarke A, et al. 2022. Cell. 185:847. PubMed
  99. Cavazzoni CB, et al. 2022. Cell Rep. 38:110399. PubMed
  100. Lederer K, et al. 2022. Cell. . PubMed
  101. Giri T, et al. 2022. Heliyon. 8:e09407. PubMed
  102. Brunk F, et al. 2021. Eur J Immunol. 51:2651. PubMed
  103. Cai D, et al. 2021. Front Mol Biosci. 8:686803. PubMed
  104. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  105. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  106. Borroto A, et al. 2022. Front Immunol. 13:799919. PubMed
  107. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  108. Li T, et al. 2022. Int J Infect Dis. 122:874. PubMed
  109. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  110. Guelen L, et al. 2022. J Immunother Cancer. 10:. PubMed
  111. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  112. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  113. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  114. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  115. Li H, et al. 2022. Front Immunol. 13:988004. PubMed
  116. Song R, et al. 2022. Front Immunol. 13:1028246. PubMed
  117. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  118. Combes AJ, et al. 2022. Cell. 185:184. PubMed
  119. He T, et al. 2022. Liver Int. 42:1287. PubMed
  120. Lee JH, et al. 2022. Cell Rep. 38:110485. PubMed
  121. Wolf EW, et al. 2022. Proc Natl Acad Sci U S A. 119:e2201794119. PubMed
  122. Tátrai P, et al. 2022. EMBO J. 41:e108739. PubMed
  123. Lei X, et al. 2022. J Exp Med. 219: . PubMed
  124. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  125. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  126. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  127. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  128. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  129. Touizer E, et al. 2023. iScience. 26:105862. PubMed
  130. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  131. Bettini E, et al. 2022. STAR Protoc. 3:101840. PubMed
  132. Guo Q, et al. 2023. Front Public Health. 10:1067342. PubMed
  133. Meyer S, et al. 2023. Cell Rep. 42:111995. PubMed
  134. Zhang S, et al. 2023. J Clin Med. 12: . PubMed
  135. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  136. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  137. Sun P, et al. 2022. iScience. 25:105202. PubMed
  138. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  139. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  140. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  141. Nihei Y, et al. 2023. Sci Adv. 9:eadd6734. PubMed
  142. Marcial-Juárez E, et al. 2023. iScience. 26:106310. PubMed
  143. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
  144. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  145. Lu T, et al. 2023. J Med Virol. 95:e28730. PubMed
  146. Fadzeyeva E, et al. 2023. iScience. 26:106748. PubMed
  147. Sigmund EC, et al. 2023. PLoS One. 18:e0285597. PubMed
  148. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed

Related FAQs

What is the F/P ratio range of our BV421™ format antibody reagents?

It is lot-specific. On average it ranges between 2-4.

Go To Top Version: 8    Revision Date: 12/18/2019

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account